在子宫内膜癌预后中hCG表达的作用
Varol Gülseren1, Mehmet Dolanbay2, Fulya Çağli2
1Department of Obstetrics and Gynecology, Division of Gynecologic Oncology.
概括
在子宫内膜腺癌 (EEC) 中,人类胆性淋巴激素 (hCG) 表达与较差的结果有关. hCG阳性表明复发风险更高,无病生存率降低,特别是在低风险的EEC.
科学领域:
- 妇科瘤学 妇科瘤学
- 生殖内分泌学 生殖内分泌学
- 癌症生物标志物 癌症生物标志物
背景情况:
- 子宫内膜类型子宫内膜癌 (EEC) 是子宫内膜癌最常见的亚型.
- 在EEC中,人类胆管性腺激素 (hCG) 表达的预后意义仍然不完全理解.
- 确定可靠的预后标志物对于量身定制治疗和改善EEC患者的治疗结果至关重要.
研究的目的:
- 为了研究人类胆管激素 (hCG) 在子宫内膜癌 (EEC) 组织中的表达模式.
- 为了评估hCG表达与EEC中的临床病理特征之间的关联.
- 确定hCG表达对EEC患者预后和生存的影响.
主要方法:
- 免疫组织化学被用来评估EEC组织样本中的hCG表达.
- 追溯分析了2010年至2020年间经过EEC手术的194名患者队列.
- 进行了统计分析,以比较hCG阳性和hCG阴性组之间的临床病理特征和生存率.
主要成果:
- hCG阳性与深层肌体侵袭,淋巴血管空间侵袭和转移性淋巴结的增加率显著相关.
- 患有hCG阳性的EEC患者的五年无病生存率 (DFS) 和整体生存率 (OS) 显著降低.
- 鉴定出hCG表达是一种独立的风险因素,在I-II级EEC复发,表面肌肉外围侵袭.
结论:
- 在子宫内膜状子宫内膜癌中hCG表达与积极的临床病理特征和更差的预后有关.
- hCG阳性作为复发和无疾病生存的负预后因素,特别是在低风险的EEC.
- 需要进一步的研究来探索hCG在EEC进展中的潜在机制及其作为治疗点的潜力.
更多相关视频
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.0K
09:15Two Methods for Establishing Primary Human Endometrial Stromal Cells from Hysterectomy Specimens
Published on: May 23, 2014
22.7K
相关概念视频
01:27Ovarian Cycle
954
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
954
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
01:22Hormonal Regulation of the Menstrual Cycle
277
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
277